These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26186204)

  • 21. Improvements on sample preparation and peptide separation for reduced peptide mapping based multi-attribute method analysis of therapeutic monoclonal antibodies using lysyl endopeptidase digestion.
    Li X; Rawal B; Rivera S; Letarte S; Richardson DD
    J Chromatogr A; 2022 Jul; 1675():463161. PubMed ID: 35635865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interlaboratory Evaluation of a User-Friendly Benchtop Mass Spectrometer for Multiple-Attribute Monitoring Studies of a Monoclonal Antibody.
    Butré CI; D'Atri V; Diemer H; Colas O; Wagner E; Beck A; Cianferani S; Guillarme D; Delobel A
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-attribute method based characterization of antibody drug conjugates (ADC) at the intact and subunit levels.
    Martelet A; Garrigue V; Zhang Z; Genet B; Guttman A
    J Pharm Biomed Anal; 2021 Jul; 201():114094. PubMed ID: 33957368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studies.
    Li Y; Monine M; Huang Y; Swann P; Nestorov I; Lyubarskaya Y
    MAbs; 2016; 8(6):1079-87. PubMed ID: 27216574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isobaric Tandem Mass Tag Multiplexed Post-Translational Modification Quantitation of Biopharmaceuticals by Targeted High-Resolution Mass Spectrometry.
    Mao Y; Kleinberg A; Li N
    Anal Chem; 2020 Jul; 92(14):9682-9690. PubMed ID: 32559367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a LC-MS based multi-attribute method (MAM) and intact multi-attribute method (iMAM) workflow for the characterisation of a GLP-Fc fusion protein.
    Buckley C; Millán-Martín S; Carillo S; Füssl F; MacHale C; Bones J
    Anal Biochem; 2024 Oct; 693():115585. PubMed ID: 38851475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute Monitoring.
    Arndt JR; Wormwood Moser KL; Van Aken G; Doyle RM; Talamantes T; DeBord D; Maxon L; Stafford G; Fjeldsted J; Miller B; Sherman M
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2019-2032. PubMed ID: 33835810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies.
    Liu P; Zhu X; Wu W; Ludwig R; Song H; Li R; Zhou J; Tao L; Leone AM
    Rapid Commun Mass Spectrom; 2019 Jan; 33(1):31-40. PubMed ID: 30286260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing.
    Li X
    J Pharm Biomed Anal; 2023 Sep; 234():115581. PubMed ID: 37494866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and optimization of a LC-MS based multi-attribute method (MAM) workflow for characterization of therapeutic Fc-fusion protein.
    Puranik A; Rasam P; Dandekar P; Jain R
    Anal Biochem; 2023 Jan; 660():114969. PubMed ID: 36343663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fully automated peptide mapping multi-attribute method by liquid chromatography-mass spectrometry with robotic liquid handling system.
    Qian C; Niu B; Jimenez RB; Wang J; Albarghouthi M
    J Pharm Biomed Anal; 2021 May; 198():113988. PubMed ID: 33676166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study.
    Mouchahoir T; Schiel JE; Rogers R; Heckert A; Place BJ; Ammerman A; Li X; Robinson T; Schmidt B; Chumsae CM; Li X; Manuilov AV; Yan B; Staples GO; Ren D; Veach AJ; Wang D; Yared W; Sosic Z; Wang Y; Zang L; Leone AM; Liu P; Ludwig R; Tao L; Wu W; Cansizoglu A; Hanneman A; Adams GW; Perdivara I; Walker H; Wilson M; Brandenburg A; DeGraan-Weber N; Gotta S; Shambaugh J; Alvarez M; Yu XC; Cao L; Shao C; Mahan A; Nanda H; Nields K; Nightlinger N; Niu B; Wang J; Xu W; Leo G; Sepe N; Liu YH; Patel BA; Richardson D; Wang Y; Tizabi D; Borisov OV; Lu Y; Maynard EL; Gruhler A; Haselmann KF; Krogh TN; Sönksen CP; Letarte S; Shen S; Boggio K; Johnson K; Ni W; Patel H; Ripley D; Rouse JC; Zhang Y; Daniels C; Dawdy A; Friese O; Powers TW; Sperry JB; Woods J; Carlson E; Sen KI; Skilton SJ; Busch M; Lund A; Stapels M; Guo X; Heidelberger S; Kaluarachchi H; McCarthy S; Kim J; Zhen J; Zhou Y; Rogstad S; Wang X; Fang J; Chen W; Yu YQ; Hoogerheide JG; Scott R; Yuan H
    J Am Soc Mass Spectrom; 2022 Sep; 33(9):1659-1677. PubMed ID: 36018776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.
    Rogers RS; Abernathy M; Richardson DD; Rouse JC; Sperry JB; Swann P; Wypych J; Yu C; Zang L; Deshpande R
    AAPS J; 2017 Nov; 20(1):7. PubMed ID: 29192343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Pohl T; Gervais A; Dirksen EHC; D'Alessio V; Bechtold-Peters K; Burkitt W; Cao L; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Jul; 188():231-242. PubMed ID: 37146738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive strategy for the identification of biologics by liquid-chromatography-mass spectrometry for release testing in a regulated environment.
    Morales A; Candreva J; Jayarathne T; Esterman AL; Voruganti S; Flagg SC; Slaney T; Liu P; Adamo M; Patel S; Das TK; Zeng M; Li X
    J Pharm Biomed Anal; 2023 Sep; 234():115580. PubMed ID: 37478550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-attribute method (MAM) to assess analytical comparability of adalimumab biosimilars.
    Millán-Martín S; Jakes C; Carillo S; Bones J
    J Pharm Biomed Anal; 2023 Sep; 234():115543. PubMed ID: 37385093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chip-Based Capillary Zone Electrophoresis Mass Spectrometry for Rapid Resolution and Quantitation of Critical Quality Attributes in Protein Biotherapeutics.
    Dykstra AB; Flick TG; Lee B; Blue LE; Angell N
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1952-1963. PubMed ID: 33730487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-Attribute Monitoring of Complex Erythropoetin Beta Glycosylation by GluC Liquid Chromatography-Mass Spectrometry Peptide Mapping.
    Buettner A; Maier M; Bonnington L; Bulau P; Reusch D
    Anal Chem; 2020 Jun; 92(11):7574-7580. PubMed ID: 32426963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Gervais A; Dirksen EHC; Pohl T; Bechtold-Peters K; Burkitt W; D'Alessio V; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Oct; 191():57-67. PubMed ID: 37582411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.